Table 1.
Study population.
| Population M ± SD N (%) |
|
|---|---|
| Gender | |
| Male | 30/50 (60%) |
| Female | 20/50 (40%) |
| Age (years) | 37.7 ± 17.9 |
| Ethnicity | |
| European | 44/50 (88%) |
| Asian | 6/50 (12%) |
| Smoker | |
| No | 37/50 (74%) |
| Yes | 13/50 (26%) |
| Duration of COVID-19 symptoms | |
| 1–4 days | 10/50 (20%) |
| 5–8 days | 27/50 (54%) |
| 8–15 days | 10/50 (20%) |
| >15 days | 3/50 (6%) |
| Comorbidities | |
| Diabetes | 3/50 (6%) |
| High blood pressure | 8/50 (16%) |
| CRS | 5/50 (10%) |
| Thyroid disease | 4/50 (8%) |
| Allergies | 10/50 (20%) |
| GERD | 14/50 (28%) |
| Asthma | 7/50 (14%) |
| Heart problems | 2/50 (4%) |
| Autoimmune disease | 4/50 (8%) |
| Follow-up (days) | 49.7 ± 18.9 |
N, number; %, percentage; M, media; SD, standard deviation;